Graphically, the patterns of IgM and IgG (Figure 1) titers progress during pregnancy describe a similar trend in the group of women undergoing VCV from the serological confirmation of infection (Group A) and those who started the therapy after positive amniocentesis in the second trimester of pregnancy (Group B). Here, CD40LG is linked to infection.